The importance of the physicochemical properties of drugs to drug metabolism

A Handbook of Bioanalysis and Drug Metabolism

Volumn , Issue , 2021, Pages 8-31

  Spalding, David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874448155     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (41)

1. Arendt, R.M., Greenblatt, D.J., deJong, R.H., Bonin, J.D., Abernethy, D.R., Ehrenberg, B.L., Giles, H.G., Sellers, E.M. and Shader, R.I. (1983) In vitro correlates of benzodiazepine cerebrospinal fluid uptake 1. Pharmacodynamic action and peripheral distribution. J. Pharmacol. Exp. Ther. 227, 98-106.
2. Belpaire, F.M., Braeckman, R.A. and Bogaert, M.G. (1984) Binding of oxprenolol and propranolol to serum albumin and α1-acid glycoprotein in man and other species. Biochem. Pharmacol. 33, 2065-2069.
3. Borgstrom, L., Nyberg, L., Jonsson, S., Linberg, C. and Paulson, J. (1989) Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as a racemate. Br. J. Clin. Pharmcol. 27, 49-56.
4. Brauman, T. (1986) Determination of hydrophobic parameters by reversed-phase liquid chromatography: theory, experimental techniques and applications in studies on quantitative structure activity relationships. J. Chromatogr. 373, 191-225.
5. Bridges, J.W. and Wilson, A.G.E. (1977) Drug-serum protein binding interactions and their biological significance. In: Progress in Drug Metabolism, Vol. 2, pp. 193-247, Bridges, J.W. and Chasseaud, L.F. (eds), Wiley Interscience, London.
6. Chapman, D., Williams, R.M. and Ladbrooke, B.D. (1967) Chem. Phys. Lipids 1, 445.
7. Crone, C. and Olensen, S.P. (1982) Electrical resistance of brain microvascular endothelium. Brain Res. 241, 49-55.
8. Edgar, B., Heggelund, A., Johansson, L., Nyberg, G. and Regardh, C.G. (1984) The pharmacokinetics of R- and S-tocainide in healthy subjects. Br. J. Clin. Pharmacol. 16, 216P-217P.
9. Eichelbaum, M., Mikus, G. and Vogelsang, B. (1984) Pharmacokinetics of (+)-, (-)- and (±) verapamil after intravenous administration. Br. J. Clin. Pharmacol. 18, 733-740.
10. Evans, A.M., Nation, R.L., Sansom, L.N., Bochner, F. and Somogyi, A.A. (1989) Stereoselective protein binding of ibuprofen enantiomers. Eur. J. Clin. Pharmacol. 36, 283-290.
11. Food and Drug Administration (1992) Policy statement for the development of new stereoisomeric drugs. Chirality 4, 338-340.
12. Fujita, T., Isawa, J. and Hansch, C. (1964) J. Amer. Chem. Soc. 86, 5175.
13. Guengerich, F.P. and MacDonald, T.L. (1990) Mechanisms of cytochrome P-450 catalysis. FASEB J. 4, 2453-2459.
14. Hansch, C. (1976) On the structure of medicinal chemistry. J. Med. Chem. 19, 1-6.
15. Hansch, C., Klein, T., McClarin, J., Langridge, R. and Cornell, N.W. (1986) A quantitative structure-activity relationship and molecular graphics analysis of hydrophobic effects in the interactions of inhibitors with alcohol dehydrogenase. J. Med. Chem. May, 29(5), 615-620.
16. Hendel, J. and Brodthages, H. (1984) Entero-hepatic cycling of methotrexate estimated by use of the D-isomer as a reference marker. Eur. J. Clin. Pharmacol. 26, 103-107.
17. Houston, J.B. and Wood, S.G. (1980) Gastrointestinal absorption of drugs and other xenobio-tics. In: Progress in Drug Metabolism, Vol. 4, pp. 57-129, Bridges, J.W. and Chasseaud, L.F. (eds), John Wiley & Sons, London.
18. Jezequel, S.G. (1992) Central nervous penetration of drugs: importance of physicochemical properties. In: Progress in Drug Metabolism, Vol. 13, pp. 141-178, Gibson, G.G. (ed.), Taylor & Francis, London.
19. Kararli, T.T. (1995) Comparison of the gastrointestinal anatomy, physiology and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Dispos. 16, 351-380.
20. Lee, E.J.D. and Williams, K.M. (1990) Chirality: clinical pharmacokinetics and pharmaco-dynamic considerations. Clin. Pharmacokinet. 18, 339-345.
21. Lima, J.J., Boudoulas, H. and Shields, B.J. (1985) Stereoselective pharmacokinetics of disopyr-amide enantiomers in man. Drug Metab. Dispos. 13, 572-577.
22. Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeney, P.J. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3-25.
23. Luscombe, D.K. and Nicholls, P.J. (1988) Processes of drug handling in the body. In: Smith and Williams' Introduction to the Principles of Drug Design, 2nd edition, pp. 1-31, Smith, H.J. (ed.), Wright, London.
24. Murray, K.T., Reilly, C., Koshakji, R.P., Roden, D.M., Lineberry, M.D., Wood, A.J.J., Siddo-way, L.A., Barbey, J.T. and Woosley, R.L. (1990) Suppression of ventricular arrythmias in man by D-propranolol independent of beta-adrenergic receptor blockade. J. Clin. Invest. 85, 836-842.
25. Ong, S., Liu, H., Qiu, X., Bhat, G. and Pidgeon, C. (1995) Membrane partition coefficients chromatographically measured using immobilised artificial membrane surfaces. Anal. Chem. 67, 755-762.
26. Pardridge, W.M. (1979) Carrier mediated transport of thyroid hormones through the rat blood -brain barrier: primary role of albumin bound hormone. Endocrinology 105 605-612.
27. Pardridge, W.M. (1988) Recent advances in blood-brain barrier transport. Ann. Rev. Pharmacol. Toxicol. 28, 25-39.
28. Rettie, A.E., Korzekwa, K.R., Kunze, K.L., Lawrence, R.F., Eddy, A.C., Aoyama, T., Gelboin, H.V., Gonzales, F.J. and Trager, W.F. (1992) Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-450 2C9 in the etiology of (S)-warfarin drug interactions. Chem. Res. Toxicol. 5, 54-59.
29. Schanker, L.S. (1964) Physiological transport of drugs. Adv. Drug Res. 1, 71-106.
30. Scherrer, R.A. and Howard, S.M. (1977) Use of distribution coefficients in quantitative structure/activity relationships. J. Med. Chem. 20, 53-58.
31. Scherrer, R.A. and Howard, S.M. (1979) The analysis of electronic factors in quantitative structure/activity relationships using distribution coefficients. In: Computer-Assisted Drug Design.ACS Symposium Series, No. 112, pp. 507-526
32. Smith, D.A. (1994) Design of drugs through a consideration of drug metabolism and pharmacokinetics. Eur. J. Drug Metab. Pharmacokinet. 3, 193-199.
33. Smith, R.N., Hansch, C. and Ames, M.M. (1975) Selection of a reference partitioning system for drug design work. J. Pharm. Sci. 64, 599-606.
34. Tenakin, T. (1993) Pharmacologic analysis of drug receptor interaction. 2nd edition. pp. 223-224, Raven press, New York.
35. Toon, S., Hopkins, K.J., Garstang, F.M. and Rowland, M. (1987) Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man. Eur. J. Clin. Pharmacol. 32, 165-172.
36. Toon, S., Low, L.K., Gibaldi, M., Trager, W.F., O'Reilly, R.A., Motley, C.H. and Goulart, D.A. (1986) The warfarin-sulfinpyrazone interaction: stereochemical considerations. Clin. Pharmacol. Ther. 39, 15-24.
37. Tracy, T.S. (1995) Stereochemistry in pharmacotherapy: when mirror images are not identical. Ann. Pharmacother. 29, 161-165.
38. Unger, S.H., Cook, J.R. and Hollenberg, J.S. (1978) Simple procedure for determining octanol-aqueous partition, distribution and ionisation coefficients by reversed-phase high pressure liquid chromatography. J. Pharm. Sci. 67, 1364-1367.
39. Vogelsang, B., Echizen, H., Schmidt, E. and Eichelbaum, M. (1984) Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique. Br. J. Clin. Pharmacol. 18, 733-740.
40. Walle, T., Webb, J.G., Bagwell, E.E., Walle, U.K., Daniell, H.B. and Gaffney, T.E. (1988) Stereo-selective delivery and actions of beta-receptor antagonists. Biochem. Pharmacol. 37, 115-124.
41. Yokogawa, K., Nakashima, E. and Ichimura, F. (1990) Effect of fat tissue volume on the distribution kinetics ofbiperidin as a function ofage in rats. DrugMetab. Dispos. 18, 258-263.